Charles Schwab’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q4 | – | Sell |
-17,792
| Closed | -$12.5K | – | 3520 |
|
2024
Q3 | $12.5K | Hold |
17,792
| – | – | ﹤0.01% | 3499 |
|
2024
Q2 | $17.8K | Sell |
17,792
-86,126
| -83% | -$86.1K | ﹤0.01% | 3596 |
|
2024
Q1 | $246K | Hold |
103,918
| – | – | ﹤0.01% | 3206 |
|
2023
Q4 | $234K | Hold |
103,918
| – | – | ﹤0.01% | 3256 |
|
2023
Q3 | $220K | Hold |
103,918
| – | – | ﹤0.01% | 3268 |
|
2023
Q2 | $321K | Buy |
103,918
+86,126
| +484% | +$266K | ﹤0.01% | 3209 |
|
2023
Q1 | $95.7K | Buy |
17,792
+6,917
| +64% | +$37.2K | ﹤0.01% | 3253 |
|
2022
Q4 | $72.3K | Hold |
10,875
| – | – | ﹤0.01% | 3299 |
|
2022
Q3 | $44K | Sell |
10,875
-30,601
| -74% | -$124K | ﹤0.01% | 3360 |
|
2022
Q2 | $207K | Sell |
41,476
-52,110
| -56% | -$260K | ﹤0.01% | 3239 |
|
2022
Q1 | $566K | Buy |
93,586
+1,251
| +1% | +$7.57K | ﹤0.01% | 3063 |
|
2021
Q4 | $1.07M | Buy |
92,335
+2,879
| +3% | +$33.5K | ﹤0.01% | 2881 |
|
2021
Q3 | $1.4M | Buy |
89,456
+20,426
| +30% | +$320K | ﹤0.01% | 2770 |
|
2021
Q2 | $1.29M | Sell |
69,030
-4,211
| -6% | -$78.6K | ﹤0.01% | 2844 |
|
2021
Q1 | $3.16M | Buy |
+73,241
| New | +$3.16M | ﹤0.01% | 2517 |
|